TrialJournal of diabetes2025

Sitagliptin, a DPP-4 Inhibitor, Effectively Promotes the Healing of Diabetic Foot Ulcer: A Randomized Controlled Trial.

Wei Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.